Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1765 studies found for:    "Liver Neoplasms"
Show Display Options
Rank Status Study
1 Completed Contrast Sonography for Evaluation of Liver Tumors Prior to Radiofrequency Ablation
Condition: Liver Neoplasms
Intervention: Drug: perflutren lipid microspheres
2 Recruiting Study Evaluating the Efficacy and Safety With CAR-T for Liver Cancer
Condition: Liver Neoplasms
Intervention: Biological: EPCAM-targeted CAR-T cells
3 Recruiting Hepatocellular Cancer (HCC) Screening in Zhongshan City
Condition: Liver Neoplasms
Intervention: Biological: Biomarker testing and Ultrasonography
4 Recruiting PET/CT-Assessment of Liver Tumor Ablation
Conditions: Liver Tumor;   Liver Neoplasms
Interventions: Radiation: N-13 ammonia;   Device: PET/CT scanner
5 Completed Single-probe Microwave Ablation (MWA) of Metastatic Liver Cancer
Condition: Liver Neoplasms
Interventions: Device: Microwave ablation;   Device: Radiofrequency ablation
6 Withdrawn Study of Pegylated Liposomal Doxorubicin and Temsirolimus in Patients With Advanced Hepatocellular Cancer
Condition: Liver Neoplasms
Intervention: Drug: Temsirolimus 25mg and Pegylated liposomal doxorubicin 25mg/m2
7 Withdrawn SCH 66336 With or Without Gemcitabine Followed by Surgery Compared With Surgery Alone in Treating Patients With Primary Liver Cancer
Condition: Liver Cancer
Interventions: Drug: gemcitabine hydrochloride;   Drug: lonafarnib;   Procedure: conventional surgery
8 Terminated
Has Results
A Phase II Trial of OSI-906 and Sorafenib in Advanced Hepatocellular Cancer
Condition: Liver Cancer
Intervention: Drug: Sorafenib and OSI-906
9 Completed
Has Results
Lenalidomide for Advanced Hepatocellular Cancer:A Phase II Trial
Condition: Liver Cancer
Intervention: Drug: lenalidomide
10 Not yet recruiting Feasibility of Electromagnetic Acoustic Imaging of Liver Tumours
Condition: Liver Tumours
Intervention: Device: Electromagnetic Acoustic Imaging
11 Active, not recruiting Dose Escalation Study of OMP-54F28 in Combination With Sorafenib in Patients With Hepatocellular Cancer
Conditions: Hepatocellular Cancer;   Liver Cancer
Intervention: Drug: OMP-54F28 with Sorafenib
12 Unknown  Lipiodol as an Imaging Biomarker in Patients With Primary and Metastatic Liver Cancer
Condition: Liver Cancer
Intervention: Drug: Lipiodol
13 Completed Taxoprexin® Treatment for Advanced Primary Cancers of the Liver
Condition: Cancer of the Liver
Intervention: Drug: Taxoprexin
14 Completed Safety and Efficiency of γδ T Cell Against Hepatocellular Liver Cancer
Condition: Liver Cancer
Interventions: Biological: DC-CIK cells;   Biological: γδ T cells;   Biological: γδ T/DC-CIK cells
15 Completed HepaSphere Interventional Therapy Using Digital Subtraction Angiography(DSA) for Liver Cancer
Condition: Liver Cancer
Intervention: Procedure: interventional therapy
16 Completed Liver Cancer HepaSphere Combined With Cryosurgery
Condition: Liver Cancer
Intervention: Procedure: HepaSphere combined with cryosurgery
17 Withdrawn Biomarkers in Stored Tumor Samples From Younger Patients With Liver Cancer
Condition: Liver Cancer
Interventions: Genetic: comparative genomic hybridization;   Genetic: molecular genetic technique;   Genetic: mutation analysis;   Genetic: polymerase chain reaction;   Genetic: proteomic profiling;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Other: mass spectrometry;   Other: medical chart review
18 Completed A Retrospective Review of Malignant Liver Tumors
Condition: Liver Cancer
Intervention:
19 Completed Irinotecan and Flavopiridol in Treating Patients With Advanced Liver Cancer
Condition: Liver Cancer
Interventions: Drug: alvocidib;   Drug: irinotecan hydrochloride
20 Recruiting Treatment of Primary Liver Tumors With Electrochemotherapy (ECT)
Condition: Liver Cancer
Interventions: Procedure: Electrochemotherapy;   Device: Cliniporator Vitae®;   Drug: Bleomycin PHC 15 e. (United States Pharmacopeia - USP)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.